SHARON BURNSIDE: Open Payments
NPI 1043231319 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,340 in 115 payments from 17 companies in 2025. Trend: 2023 $2,633 · 2024 $2,307 · 2025 $2,340
Food & beverage: $2,340
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 23 | $494 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $366 |
| Vanda Pharmaceuticals Inc. | 8 | $245 |
| Teva Pharmaceuticals USA, Inc. | 12 | $218 |
| Axsome Therapeutics, Inc. | 12 | $204 |
| Alkermes, Inc. | 7 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $136 |
| Lundbeck LLC | 6 | $117 |
| Janssen Pharmaceuticals, Inc | 4 | $79 |
| Corium, LLC | 3 | $70 |
Products named: INGREZZA, CAPLYTA, AUSTEDO XR, HETLIOZ, REXULTI, Auvelity, TRINTELLIX, ARISTADA.
Industry payments across TN — which companies pay providers there.
